Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli

Protein Expression and Purification

Volumn 66, Issue 2, 2009, Pages 191-197

  Gong, Zhaohui ^a   Long, Xiang'e ^a   Pan, Lin ^a   Le, Yanping ^a   Liu, Qiong ^a   Wang, Shaomin ^a   Guo, Junming ^a   Xiao, Bingxiu ^a   Zhou, Mi ^a   Mei, Disen ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Autoimmune diabetes; Cholera toxin B subunit; Glutamic acid decarboxylase 65; Oral tolerance

Indexed keywords

AUTOANTIGEN; CHOLERA TOXIN; GANGLIOSIDE GM1; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; HYBRID PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOREACTOR; CYTOCHEMISTRY; CYTOLOGY; DISEASE MODEL; ESCHERICHIA COLI; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; METABOLISM; MOLECULAR GENETICS; MOUSE; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; PANCREAS ISLET;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; BASE SEQUENCE; BIOREACTORS; CHOLERA TOXIN; CHROMATOGRAPHY, AFFINITY; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; G(M1) GANGLIOSIDE; GLUTAMATE DECARBOXYLASE; HISTOCYTOCHEMISTRY; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

EID: 65549135528     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.04.002     Document Type: Article

References (42)

1. Garside P., and Mowat A.M. Oral tolerance. Semin. Immunol. 13 (2001) 177-185
2. Ma S.W., Zhao D.L., Yin Z.Q., Mukherjee R., Singh B., Qin H.Y., Stiller C.R., and Jevnikar A.M. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat. Med. 3 (1997) 793-796
3. Maron R., Guerau-de-Arellano M., Zhang X., and Weiner H.L. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. J. Autoimmun. 16 (2001) 21-28
4. Ma S., Huang Y., Yin Z., Menassa R., Brandle J.E., and Jevnikar A.M. Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proc. Natl. Acad. Sci. USA 101 (2004) 5680-5685
5. Petersen J.S., Bregenholt S., Apostolopolous V., Homann D., Wolfe T., Hughes A., De K.J., Wang M., Dyrberg T., and Von Herrath M.G. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin. Exp. Immunol. 134 (2003) 38-45
6. Gong Z.H., Jin Y.F., and Zhang Y.Z. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes. J. Biotechnol. 119 (2005) 93-105
7. Gong Z.H., Jin Y.F., and Zhang Y.Z. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine expressed in silkworm. Vaccine 25 (2007) 1444-1451
8. Pierre P., Denis O., Bazin H., Mbongolo E.M., and Vaerman J.P. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Eur. J. Immunol. 22 (1992) 3179-3182
9. Sun J.B., Holmgren J., and Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral tolerance. Proc. Natl. Acad. Sci. USA 91 (1994) 10795-10799
10. Sun J.B., Rask C., Olson T., Holmgren J., and Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93 (1996) 7196-7201
11. Bergerot I., Ploix C., Petersen J., Moulin V., Rask C., Fabien N., Lindblad M., Mayer A., Czerkinsky C., Holmgren J., and Thivolet C. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94 (1997) 4610-4614
12. McSorley S.J., Rask C., Pichot R., Julia V., Czerkinsky C., and Glaichenhaus N. Selective tolerization of Th1-like cells after nasal administration of cholera toxoid-LACK conjugate. Eur. J. Immunol. 28 (1998) 424-432
13. Sun J.B., Li B.L., Czerkinsky C., and Holmgren J. Enhanced immunological tolerance against allograft rejection by oral administration of allogenic antigen linked to cholera toxin B subunit. Clin. Immunol. 97 (2000) 130-139
14. Rask C., Holmgren J., Frederiksson M., Lindblad M., Nordström I., Sun J.B., and Czerkinsky C. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin. Exp. Allergy 30 (2000) 1024-1032
15. Burkart V., Kim Y., Kauer M., and Kolb H. Induction of tolerance in macrophages by cholera toxin B chain. Pathobiology 67 (1999) 314-317
16. Li T.K., and Fox B.S. Cholera toxin B subunit binding to an antigen presenting cell directly co-stimulates cytokine production from a T cell clone. Int. Immunol. 8 (1996) 1849-1856
17. Maeyama J., Isaka M., Yasuda Y., Matano K., Kozuka S., Taniguchi T., Ohkuma K., Tochikubo K., and Goto N. Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Microbiol. Immunol. 45 (2001) 111-117
18. Anjuere F., George-Chandy A., Audant F., Rousseau D., Holmgren J., and Czerkinsky C. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses. J. Immunol. 170 (2003) 1586-1592
19. Bregenholt S., Wang M., Wolfe T., Hughes A., Baerentzen L., Dyrberg T., von Herrath M.G., and Petersen J.S. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Scand. J. Immunol. 57 (2003) 432-438
20. Holmgren J., Adamsson J., Anjuere F., Clemens J., Czerkinsky C., Eriksson K., Flach C.F., George-Chandy A., Harandi A.M., Lebens M., Lehner T., Lindblad M., Nygren E., Raghavan S., Sanchez J., Stanford M., Sun J.B., Svennerholm A.M., and Tengvall S. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol. Lett. 97 (2005) 181-188
21. Zhang P., Yang Q.B., Balkovetz D.F., Lewis J.P., Clements J.D., Michalek S.M., and Katz J. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. Vaccine 23 (2005) 4734-4744
22. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., and Kaufman D.L. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183 (1996) 1561-1567
23. Ogino T., Sato K., Miyokawa N., Kimura S., and Katagiri M. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice. Immunogenetics 51 (2000) 538-545
24. Quinn A., McInerney B., Reich E.P., Kim O., Jensen K.P., and Sercarz E.E. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J. Immunol. 166 (2001) 2982-2991
25. Arêas A.P., Oliveira M.L., Ramos C.R., Sbrogio-Almeida M.E., Raw I., and Ho P.L. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6×His-tagged protein in Escherichia coli. Protein Expr. Purif. 25 (2002) 481-487
26. Charlton B., and Mandel T.E. Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes. Diabetes 37 (1988) 1108-1112
27. Brooking H., Powell M.J., Amoroso M., Betterle C., Pedini B., Coco G., Furmaniak J., and Smith B.R. Preparation and testing of diabetes autoantibody controls. Ann. NY Acad. Sci. 1150 (2008) 316-319
28. Uibo R., and Lernmark A. GAD65 autoimmunity-clinical studies. Adv. Immunol. 100 (2008) 39-78
29. Ludvigsson J., Faresjö M., Hjorth M., Axelsson S., Chéramy M., Pihl M., Vaarala O., Forsander G., Ivarsson S., Johansson C., Lindh A., Nilsson N.O., Aman J., Ortqvist E., Zerhouni P., and Casas R. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 359 (2008) 1909-1920
30. Kim T.G., Huy N.X., Kim M.Y., Jeong D.K., Jang Y.S., Yang M.S., Langridge W.H., and Lee J.Y. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli. Mol. Biotechnol. 41 (2009) 157-164
31. Donayre Torres A.J., Esquivel Soto E., Gutierrez Xicotencatl M.d.L., Esquivel Guadarrama F.R., and Gomez Lim M.A. Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli. Virol. J. 6 (2009) 17
32. Choi N.W., Estes M.K., and Langridge W.H. Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato. Mol. Biotechnol. 31 (2005) 193-202
33. Shin E.A., Lee J.Y., Kim T.G., Park Y.K., and Langridge W.H. Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. Protein Expr. Purif. 47 (2006) 99-109
34. Sharma M.K., Jani D., Thungapathra M., Gautam J.K., Meena L.S., Singh Y., Ghosh A., Tyagi A.K., and Sharma A.K. Expression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). J. Biotechnol. 135 (2008) 22-27
35. Sharma M.K., Singh N.K., Jani D., Sisodia R., Thungapathra M., Gautam J.K., Meena L.S., Singh Y., Ghosh A., Tyagi A.K., and Sharma A.K. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Rep. 27 (2008) 307-318
36. Li D., O'Leary J., Huang Y., Huner N.P., Jevnikar A.M., and Ma S. Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants. Plant Cell Rep. 25 (2006) 417-424
37. Ruhlman T., Ahangari R., Devine A., Samsam M., and Daniell H. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts-oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J. 5 (2007) 495-510
38. Rosales-Mendoza S., Alpuche-Solís A.G., Soria-Guerra R.E., Moreno-Fierros L., Martínez-González L., Herrera-Díaz A., and Korban S.S. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. Plant J. 57 (2009) 45-54
39. Matoba N., Kajiura H., Cherni I., Doran J.D., Bomsel M., Fujiyama K., and Mor T.S. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. Plant Biotechnol. J. 7 (2009) 129-145
40. Thangadurai C., Suthakaran P., Barfal P., Anandaraj B., Pradhan S.N., Ramalingam S., and Murugan V. Rare codon priority and its position specificity at the 5′ of the gene modulates heterologous protein expression in Escherichia coli. Biochem. Biophys. Res. Commun. 376 (2008) 647-652
41. J.W. Seo, W.K. Hong, D. Rairakhwada, P.S. Seo, M.H. Choi, K.B. Song, S.K. Rhee, C.H. Kim, An efficient plasmid vector for constitutive high-level expression of foreign genes in Escherichia coli, Biotechnol. Lett. (2009), doi:10.1007/s10529-009-9941-4.
42. Koo T.Y., and Park T.H. Expression of recombinant human growth hormone in a soluble form in Escherichia coli by slowing down the protein synthesis rate. J. Microbiol. Biotechnol. 17 (2007) 579-585